Moreover, we demonstrate that NG2 knockout does not affect tumor growth in vitro and in vivo, but enhances the response of BRAF-mutant thyroid cancer cells to BRAF inhibitor. The gene discussed is CSPG4; the disease is thyroid gland carcinoma.